Trade Pulmonx Corporation - LUNG CFD
Add to favourite- Summary
- Historical Data
Spread | 0.05 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 7.5 |
Open | 7.31 |
1-Year Change | -41.05% |
Day's Range | 7.09 - 7.31 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Apr 25, 2024 | 7.29 | 0.06 | 0.83% | 7.23 | 7.32 | 7.08 |
Apr 24, 2024 | 7.50 | 0.14 | 1.90% | 7.36 | 7.64 | 7.35 |
Apr 23, 2024 | 7.48 | 0.22 | 3.03% | 7.26 | 7.54 | 7.26 |
Apr 22, 2024 | 7.36 | -0.05 | -0.67% | 7.41 | 7.52 | 7.34 |
Apr 19, 2024 | 7.48 | 0.27 | 3.74% | 7.21 | 7.72 | 7.21 |
Apr 18, 2024 | 7.48 | 0.05 | 0.67% | 7.43 | 7.48 | 7.18 |
Apr 17, 2024 | 7.41 | -0.01 | -0.13% | 7.42 | 7.56 | 7.29 |
Apr 16, 2024 | 7.40 | 0.02 | 0.27% | 7.38 | 7.54 | 7.31 |
Apr 15, 2024 | 7.45 | -0.32 | -4.12% | 7.77 | 7.89 | 7.36 |
Apr 12, 2024 | 7.87 | -0.11 | -1.38% | 7.98 | 8.21 | 7.69 |
Apr 11, 2024 | 8.31 | 0.19 | 2.34% | 8.12 | 8.37 | 8.12 |
Apr 10, 2024 | 8.29 | 0.05 | 0.61% | 8.24 | 8.41 | 8.13 |
Apr 9, 2024 | 8.62 | 0.47 | 5.77% | 8.15 | 8.67 | 8.14 |
Apr 8, 2024 | 8.37 | 0.38 | 4.76% | 7.99 | 8.43 | 7.98 |
Apr 5, 2024 | 8.20 | 0.47 | 6.08% | 7.73 | 8.22 | 7.53 |
Apr 4, 2024 | 7.82 | -0.07 | -0.89% | 7.89 | 8.01 | 7.76 |
Apr 3, 2024 | 7.91 | -0.64 | -7.49% | 8.55 | 8.55 | 7.85 |
Apr 2, 2024 | 8.49 | -0.22 | -2.53% | 8.71 | 8.94 | 8.34 |
Apr 1, 2024 | 9.08 | -0.11 | -1.20% | 9.19 | 9.21 | 8.97 |
Mar 28, 2024 | 9.22 | 0.18 | 1.99% | 9.04 | 9.43 | 9.04 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Pulmonx Corporation Company profile
About Pulmonx Corp
Pulmonx Corporation is a commercial-stage medical technology company. The Company provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The Company’s solutions include Zephyr Endobronchial Valve, Chartis Pulmonary Assessment System and StratX Lung Analysis Platform, which is designed to treat severe emphysema patients. Its solution provides bronchoscopic lung volume reduction without surgery. The Zephyr Valves are indicated for bronchoscopic treatment of adult patients with hyperinflation associated with severe emphysema in regions of the lung that have little to no collateral ventilation. The Zephyr Valves are placed in the airways to occlude the diseased parts of the lung, allowing trapped air to escape.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Pulmonx Corp revenues increased 48% to $48.4M. Net loss increased 51% to $48.7M. Revenues reflect United States segment increase of 54% to $25M, Europe, Middle-East and Africa ("EMEA") segment increase of 44% to $19.9M. Higher net loss reflects Selling, general and administrative increase of 41% to $61.2M (expense), Stock-based Compensation in SGA increase from $2.8M to $8.7M (expense).
Industry: | Medical Equipment |
700 Chesapeake Dr
REDWOOD CITY
CALIFORNIA 94063
US
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com